Skip to Content

Nebivolol and valsartan Approval Status

  • FDA approved: No
  • Generic name: nebivolol and valsartan
  • Company: Forest Laboratories, Inc.
  • Treatment for: High Blood Pressure

Nebivolol/Valsartan is an investigational fixed dose combination in development for the treatment of hypertension. In December 2014, the FDA issued a Complete Response Letter for the fixed-dose combination (FDC) of nebivolol and valsartan.

FDA Approval Status for nebivolol and valsartan

Dec 24, 2014Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension
Feb 27, 2014Forest Laboratories Submits NDA for Nebivolol and Valsartan Combination in Hypertension

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.